Nayre, Allan L.
HRN: 26-16-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2024
AZITHROMYCIN 500MG TABLET (TAB)
11/02/2024
11/06/2024
PO
500mg
OD
Presumptive PTB; CAP-MR; T/c COPD In AE
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes